Study Learning from Men Treated for Prostate Cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial looks at long-term results after radiation therapy for prostate cancer. By studying PSA test results and imaging scans from men who were treated at least 10 years ago, researchers hope to learn more about side effects and how well the treatment worked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had radiation therapy for prostate cancer at least 10 years ago and finished your full treatment course.
- You have had regular PSA tests after your radiation therapy.
- You have had a CT scan for diagnosis and a separate CT scan used to plan your radiation therapy.
- Your doctors still have your treatment planning records and your health records (like notes about side effects).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with prostate cancer who receive radiation to understand what side effects and quality-of-life changes happen over time. It may help improve standard follow-up care by better tracking radiation-related toxicity.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
This Phase 3 study compares an immediate curative treatment plan versus a more conservative approach in men age 75 and older with newly diagnosed, high-risk prostate cancer. The goal is to see which strategy controls the cancer while better protecting quality of life.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
This study looks at specific gene changes (TMPRSS2-ERG fusion and PTEN deletion) in people whose prostate cancer returned after radiation. It aims to understand who may have a higher risk of relapse and help predict outcomes after salvage or radical radiation.
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.